Editors:
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (17 chapters)
-
Front Matter
-
Back Matter
Reviews
From Book News, Inc.
A class of antitumor agents is discussed in 16 papers, which include explorations of the synthesis, chemical properties, biotransformation, and pharmacokinetics in animals and humans, and studies of analogous agents and substances affecting the mechanism of triazenes. Specific topics include antimetastatic action, immune responses, xenogenization, clinical use, and therapeutic considerations.
Annotation copyright Book News, Inc. Portland, Or.
Editors and Affiliations
-
Istituto di Farmacologia, Università di Trieste, Trieste, Italy
Tullio Giraldi
-
Toxicology Unit, Medical Research Council, Carshalton, Surrey, UK
Thomas A. Connors
-
Divisione di Oncologia Medica, Ospedale S. Maria della Misericordia, Udine, Italy
Giuseppe Cartei
Bibliographic Information
Book Title: Triazenes
Book Subtitle: Chemical, Biological, and Clinical Aspects
Editors: Tullio Giraldi, Thomas A. Connors, Giuseppe Cartei
DOI: https://doi.org/10.1007/978-1-4615-3832-5
Publisher: Springer New York, NY
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Science+Business Media New York 1990
Hardcover ISBN: 978-0-306-43667-3Published: 01 January 1991
Softcover ISBN: 978-1-4613-6710-9Published: 17 October 2012
eBook ISBN: 978-1-4615-3832-5Published: 06 December 2012
Edition Number: 1
Number of Pages: VIII, 227
Topics: Oncology, Cancer Research, Biochemistry, general